Frequency, heterogeneity and encephalitogenicity of T cells specific for myelin oligodendrocyte glycoprotein in naive outbred primates

Auto‐reactive T cells present in healthy subjects remain in a state of unresponsiveness, but may trigger autoimmunity under various situations. Although myelin oligodendrocyte glycoprotein (MOG) is a potential target antigen in multiple sclerosis (MS), MOG‐reactive T cell responses are present in the blood of both healthy subjects and MS‐affected individuals. To investigate the disease‐inducing potential and regulation of these autoreactive T cells in healthy outbred populations, we have characterized MOG‐reactive T cell clones obtained by limiting dilution from peripheral blood ofunimmunized C. jacchus marmosets. We report an extraordinarily high prevalence of circulating MOG‐reactive T cells in these naive animals (2.6 ± 1.4 / 105 PBMC), and a broadly diverse repertoire of epitope recognition encompassing at least three regions within the extracellular domain of MOG. Adoptive transfer of a MOG21 – 40‐specific T cell clone resulted in mild clinical experimental allergic encephalomyelitis, characterized pathologically by rare foci of inflammation and minimal demyelination. We conclude that MOG‐reactive T cells are present in healthy primates at a highly prevalent frequency, and are potentially capable of triggering central nervous system autoimmunity. Expansion of these autoreactive T cells must be tightly controlled to maintain immune homeostasis in healthy individuals.

[1]  Eric O Long,et al.  Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. , 1990, Journal of immunology.

[2]  N. Letvin,et al.  Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. , 1995, The Journal of clinical investigation.

[3]  A. Naji,et al.  Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide , 2001, Nature Immunology.

[4]  L. Hood,et al.  Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity , 1993, Cell.

[5]  Stephen L Hauser,et al.  Autoreactivity to myelin antigens: myelin/oligodendrocyte glycoprotein is a prevalent autoantigen , 1999, Journal of Neuroimmunology.

[6]  T. Olsson,et al.  T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. , 1991, Journal of immunology.

[7]  S. Hauser,et al.  Late Complications of Immune Deviation Therapy in a Nonhuman Primate , 1996, Science.

[8]  S. Hauser,et al.  Fine specificities of T cell and B cell responses to myelin/oligodendrocyte glycoprotein in common marmosets , 1998, Journal of Neuroimmunology.

[9]  R. Milo,et al.  Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. , 1993, The Journal of clinical investigation.

[10]  C. Brosnan,et al.  Mechanisms of Immune Injury in Multiple Sclerosis , 1996, Brain pathology.

[11]  S. Hauser,et al.  Characterization of the response to myelin basic protein in a non human primate model for multiple sclerosis , 2001, European journal of immunology.

[12]  K. Nicolay,et al.  Myelin/Oligodendrocyte Glycoprotein-Induced Autoimmune Encephalomyelitis in Common Marmosets: The Encephalitogenic T Cell Epitope pMOG24–36 Is Presented by a Monomorphic MHC Class II Molecule1 , 2000, The Journal of Immunology.

[13]  A. Cross,et al.  B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide , 1999, European journal of immunology.

[14]  H. Wekerle,et al.  Autoaggressive T lymphocyte lines recognizing the encephalitogenic region of myelin basic protein: in vitro selection from unprimed rat T lymphocyte populations. , 1985, Journal of immunology.

[15]  R. Kinkel,et al.  The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis , 1998, Immunological reviews.

[16]  A. Ben-nun,et al.  Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: Reactivity to the extracellular domain of MOG is directed against three main regions , 1997, European journal of immunology.

[17]  A. Ben-nun,et al.  Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: diverse Vβ gene usage by T cells recognizing the core epitope encephalitogenic for T cell receptor Vβb and T cell receptor Vβa H‐2b mice , 1996 .

[18]  H. Lassmann,et al.  T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system , 1993, European journal of immunology.

[19]  D. Pham‐Dinh,et al.  Development of Myelin Oligodendrocyte Glycoprotein Autoreactive Transgenic B Lymphocytes: Receptor Editing In Vivo After Encounter of a Self-Antigen Distinct from Myelin Oligodendrocyte Glycoprotein , 2000, The Journal of Immunology.

[20]  B. Devaux,et al.  Induction of EAE in mice with recombinant human MOG, and treatment of EAE with a MOG peptide , 1997, Journal of Neuroimmunology.

[21]  P. Villoslada,et al.  Human Nerve Growth Factor Protects Common Marmosets against Autoimmune Encephalomyelitis by Switching the Balance of T Helper Cell Type 1 and 2 Cytokines within the Central Nervous System , 2000, The Journal of experimental medicine.

[22]  R. Hohlfeld,et al.  Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives. , 1997, Brain : a journal of neurology.

[23]  I. Cohen,et al.  Autoimmunity, microbial immunity and the immunological homunculus. , 1991, Immunology today.

[24]  H. Lassmann,et al.  Encephalitogenic potential of myelin basic protein-specific T cells isolated from normal rhesus macaques. , 1997, The American journal of pathology.

[25]  I. Cohen,et al.  The cognitive principle challenges clonal selection. , 1992, Immunology today.

[26]  D. Bourdette,et al.  Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis , 1992, Journal of Neuroimmunology.

[27]  M. Itoh,et al.  IgG subclass switching is associated with the severity of experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein peptide in NOD mice. , 1999, Cellular immunology.

[28]  J. Fjell,et al.  B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. , 1998, Journal of immunology.

[29]  H. Lassmann,et al.  Butyrophilin, a Milk Protein, Modulates the Encephalitogenic T Cell Response to Myelin Oligodendrocyte Glycoprotein in Experimental Autoimmune Encephalomyelitis1 , 2000, The Journal of Immunology.

[30]  I. Dozmorov,et al.  Limiting dilution analysis: from frequencies to cellular interactions. , 2000, Immunology today.

[31]  C. Bernard,et al.  Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein. , 1998, Autoimmunity.

[32]  J. Strominger,et al.  Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein , 1995, Cell.

[33]  J. Liu,et al.  Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55. , 1996, Journal of immunology.

[34]  D. Hafler,et al.  Direct Ex Vivo Analysis of Activated, Fas-sensitive Autoreactive T Cells in Human Autoimmune Disease , 1997, The Journal of experimental medicine.

[35]  O. Majdic,et al.  Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. , 1994, Journal of immunology.

[36]  R. Ferrante,et al.  In healthy primates, circulating autoreactive T cells mediate autoimmune disease. , 1994, The Journal of clinical investigation.

[37]  S. Hauser,et al.  Allergic Encephalomyelitis in Common Marmosets: Pathogenesis of a Multiple Sclerosis-like Lesion , 1996, Methods.

[38]  S. Hauser,et al.  The T‐cell response to myelin basic protein in familial multiple sclerosis: Diversity of fine specificity, restricting elements, and T‐cell receptor usage , 1993, Annals of neurology.

[39]  T. Johns,et al.  The Structure and Function of Myelin Oligodendrocyte Glycoprotein , 1999, Journal of neurochemistry.

[40]  E. Shevach Regulatory T cells in autoimmmunity*. , 2000, Annual review of immunology.

[41]  H. Lassmann,et al.  The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat , 1995, Journal of Neuroimmunology.

[42]  R. Voskuhl Myelin protein expression in lymphoid tissues: implications for peripheral tolerance , 1998, Immunological reviews.

[43]  Klaus-Armin Nave,et al.  Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells , 2000, Nature Medicine.

[44]  E. Sercarz,et al.  The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease , 1993, The Journal of experimental medicine.

[45]  S. Hauser,et al.  Identification of autoantibodies associated with myelin damage in multiple sclerosis , 1999, Nature Medicine.

[46]  R. Hohlfeld,et al.  Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein. , 1999, Brain : a journal of neurology.

[47]  H. Wekerle,et al.  Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T–T cell interactions , 1988, Nature.

[48]  Jingwu Z. Zhang,et al.  Myelin basic protein–specific T lymphocytes in multiple sclerosis and controls: Precursor frequency, fine specificity, and cytotoxicity , 1992, Annals of neurology.

[49]  B. Engelhardt,et al.  Lymphocyte Targeting of the Central Nervous System: A Review of Afferent and Efferent CNS‐Immune Pathways , 1996, Brain pathology.

[50]  S. Miller,et al.  Evolution of the T‐Cell Repertoire during the Course of Experimental Immune‐Mediated Demyelinating Diseases , 1995, Immunological reviews.

[51]  V. Kuchroo,et al.  High Frequency of Autoreactive Myelin Proteolipid Protein–Specific T Cells in the Periphery of Naive Mice , 2000, The Journal of experimental medicine.

[52]  C. Linington,et al.  Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily , 1992, Journal of neuroscience research.

[53]  A. Ben-nun,et al.  Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)‐derived peptide: Preliminary analysis of MOG T cell epitopes , 1995, European journal of immunology.

[54]  L. Steinman,et al.  The T lymphocyte in experimental allergic encephalomyelitis. , 1990, Annual review of immunology.

[55]  H. Lassmann,et al.  Differential Ultrastructural Localization of Myelin Basic Protein, Myelin/Oligodendroglial Glycoprotein, and 2′,3′‐Cyclic Nucleotide 3′‐Phosphodiesterase in the CNS of Adult Rats , 1989, Journal of neurochemistry.

[56]  J. Frank,et al.  Determinant spreading associated with demyelination in a nonhuman primate model of multiple sclerosis. , 1999, Journal of immunology.

[57]  H. Weiner,et al.  A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. , 1987, Journal of immunology.

[58]  S. Hauser,et al.  Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: A case for antigen‐specific antibody mediation , 1999, Annals of neurology.

[59]  R. Sobel,et al.  Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice , 1999, Journal of Neuroimmunology.